eBay, QUALCOMM, Valeant Downgraded

eBay, QUALCOMM, and Valeant stocks received bearish analyst attention

Apr 20, 2017 at 9:55 AM
facebook X logo linkedin

Analysts are weighing in on online retailer eBay, chip stock QUALCOMM, Inc. (NASDAQ:QCOM), and drugmaker Valeant Pharmaceuticals Intl Inc (NYSE:VRX). Here's a quick roundup of today's bearish brokerage notes on EBAY stock, as well as shares of QCOM and VRX.

EBAY Stock Sinks on Outlook, Downgrade

EBAY is down 3% at $32.85, as a gloomy profit forecast overshadows an earnings beat. Reacting to the news, Monness Crespi Hardt downgraded the stock's rating to "neutral" from "buy," unlike RBC, which hiked its price target to $36 from $34 -- in record-high territory. Canaccord Genuity also increased its price target, to $32 from $31. In spite of today's losses, eBay stock remains 33% higher year-over-year. Options traders are probably hoping the shares can quickly recover from today's setback. During the past 50 days at the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX), EBAY stock has amassed a call/put volume ratio of 2.89 -- in the top quartile of its annual range.

QUALCOMM Earnings Panned by Wall Street

QCOM's earnings report was better than expected, but that didn't earn the firm much respect from analysts. While Stifel did lift its price target by $1 to $65, at least another four brokerage firms slashed their target prices. Plus, Canaccord Genuity said the company's ongoing legal woes with Apple Inc. (NASDAQ:AAPL) "remains a key issue impacting the share price." Out of the gate, QUALCOMM, Inc. shares are 0.7% higher at $52.97. Longer term, though, it's been a struggle for the stock, down sharply from its late-October high near $72. Perhaps that's why options traders have recently been targeting puts over calls. QCOM stock's 10-day ISE/CBOE/PHLX put/call volume ratio of 0.78 sits just 17 percentage points from a 12-month peak.

Valeant Stock Stung by Price-Target Reduction

J.P. Morgan Securities slashed its price target on VRX stock to $10 from $15. The decision is well-deserved, considering the shares were down 73% year-over-year heading into today. Out of the gate, Valeant Pharmaceuticals Intl Inc has shed another 0.5% at $8.97. Speaking more broadly to VRX stock's sentiment backdrop, the brokerage crowd has expressed high levels of negativity -- with 80% of covering analysts dishing out a "hold" or "strong sell" recommendation.


Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on C3.ai calls
238.5% GAIN on Oracle calls



Rainmaker Ads CGI